Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer model

Takashi Ninomiya, Nagio Takigawa, Eiki Ichihara, Nobuaki Ochi, Toshi Murakami, Yoshihiro Honda, Toshio Kubo, Daisuke Minami, Kenichiro Kudo, Mitsune Tanimoto, Katsuyuki Kiura

Research output: Contribution to journalArticlepeer-review

56 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Afatinib prolongs survival compared with gefitinib in an epidermal growth factor receptor-driven lung cancer model'. Together they form a unique fingerprint.

Medicine & Life Sciences